Veeva Systems (VEEV) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Veeva Systems · Health Care · ref. ETF XLV · 86 calls · price $301.63
What the company does: Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
📈 Veeva Systems (VEEV) stock price
$301.63+4.9% over range
Oct 14, 25low $151.43 · high $301.63Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
65% recommend buying · 20 analysts
📊 JPI status : Veeva Systems has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 VEEV price target & analyst consensus — price $302
The price target · all analysts combined (20 targets)
Highest target · 1 firm of 20$340+12.7%
Median target · of 20 targets$295-2.2%
Lowest target · 1 firm of 20$165-45.3%
Current price$301.63
Where these 20 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
840%
$305 ↔ $340
Below
1260%
$165 ↔ $300
⏳ Targets haven't kept up with the price. 65% of ratings say “Buy”, yet 12 of 20 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (240 calls tested). It aims for $270 (-10 %), call made on August 28, 2026, maturing on August 28, 2027 (47 d ago).
The 16 reliable analysts
$287-5.0 %
The 4 other firms
$323+6.9 %
How to read it: the 16 reliable firms are not filtered by optimism — 5 aim above the price, 11 below, hence their $287 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 20 ratings (last 6 months)
Strong Buy00%
Buy1365%
Hold630%
Sell15%
Strong Sell00%
Go deeper on the analysts
🎯 VEEV price target all
All 21 calls, one by one, with our verdict on each firm.
→ See all 21 targets, analyst by analyst💡 The best analysts on VEEV most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in VEEV? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Veeva Systems? The JPI assistant answers using our backtest data.
📈 Veeva Systems fundamentals: valuation, margins & growth › open the full page
P/E 49.4Net margin 29.3 %Revenue growth +17.6 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 23 %
2024
Rev +10%Profit +8%
2025
Rev +16%Profit +36%
2026
Rev +16%Profit +27%
🔎 Detailed analyses
🏛️ Which US Congress members hold Veeva Systems (VEEV)?
1 Congress member has disclosed VEEV buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
William Keating 2× · 43%
✅ Historical analyst reliability on VEEV
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +79.1% | 3 |
| DA Davidson ↗ | 100% | +77.8% | 2 |
| B of A Securities ↗ | 100% | +40.5% | 5 |
| BTIG ↗ | 100% | +31.1% | 2 |
| Canaccord Genuity ↗ | 88% | +52.6% | 8 |
| Goldman Sachs ↗ | 83% | +13.5% | 6 |
| Raymond James ↗ | 76% | +11.9% | 17 |
| Morgan Stanley ↗ | 75% | +31.3% | 32 |
| JMP Securities | 73% | +19.2% | 11 |
| Keybanc ↗ | 71% | +19.6% | 21 |
See the other 19 firms
| Deutsche Bank ↗ | 0% | -20.1% | 5 |
| Jefferies ↗ | 0% | -3.0% | 2 |
| Pacific Crest | 33% | +0.3% | 3 |
| UBS ↗ | 33% | +6.1% | 3 |
| Wells Fargo ↗ | 40% | -6.9% | 5 |
| Mizuho ↗ | 50% | -8.4% | 4 |
| SVB Leerink | 50% | -3.0% | 4 |
| JP Morgan ↗ | 50% | +30.0% | 4 |
| Citigroup ↗ | 53% | +3.7% | 15 |
| Needham ↗ | 58% | +8.4% | 26 |
| Barclays ↗ | 60% | +8.2% | 15 |
| Stephens & Co. ↗ | 60% | +23.1% | 5 |
| Baird ↗ | 62% | +23.9% | 16 |
| RBC Capital ↗ | 64% | +7.1% | 11 |
| Piper Sandler ↗ | 65% | +15.6% | 26 |
| Truist Securities ↗ | 67% | +2.2% | 3 |
| Guggenheim ↗ | 67% | +40.5% | 6 |
| Stifel ↗ | 68% | +34.6% | 19 |
| Oppenheimer ↗ | 71% | +7.0% | 7 |
📊 What $1,000 invested in Veeva Systems would be worth › open the full page
In short — $1,000 invested in Veeva Systems 10 years ago would be worth $6,151 today, i.e. +20%/yr on average. Best year: 2020 (+94%), worst: 2022 (-37%). Price performance, excluding dividends.
If I'd invested $1,000 in Veeva Systems
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $844 | -16% |
| 3 years ago | $1,100 | +10% |
| 5 years ago | $652 | -35% |
Return by year (Veeva Systems)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -20% | $795 (-20%) |
| 2025 | +6% | $844 (-16%) |
| 2024 | +9% | $922 (-8%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Veeva Systems
Loading news…
📋 All analyst calls on VEEV
Filtered on — · ✕ show all
■ Neutral neutral · not a buy · 🎯$273
Price at call : $285.69 — gap to target -4%
Today : $301.63 — gap to target -9%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Aug 28, 27
matures : Aug 28, 27
▲ Outperform · 🎯$280
Price at call : $276.69 — upside +1%
Today : $301.63 — upside -7%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
BMO Capital ↗
Aug 27, 26
■ Market Perform neutral · not a buy · 🎯$270
Price at call : $276.69 — gap to target -2%
Today : $301.63 — gap to target -10%
🎯 on VEEV : no call matured yet · 📊 on Health : 60.4% · +8.8% (240 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Outperform · 🎯$300
Price at call : $276.69 — upside +8%
Today : $301.63 — upside -1%
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Canaccord Genuity ↗
Aug 27, 26
■ Hold neutral · not a buy · 🎯$260
Price at call : $276.69 — gap to target -6%
Today : $301.63 — gap to target -14%
🎯 on VEEV : no call matured yet · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Buy · 🎯$283
Price at call : $276.69 — upside +2%
Today : $301.63 — upside -6%
🎯 on VEEV : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Overweight · 🎯$315
Price at call : $276.69 — upside +14%
Today : $301.63 — upside +4%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
■ Neutral neutral · not a buy · 🎯$290
Price at call : $276.69 — gap to target +5%
Today : $301.63 — gap to target -4%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
See the other 78 calls, newest to oldest
RBC Capital ↗
Aug 27, 26
▲ Outperform · 🎯$325
Price at call : $276.69 — upside +17%
Today : $301.63 — upside +8%
🎯 on VEEV : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Guggenheim ↗
Aug 27, 26
▲ Buy · 🎯$310
Price at call : $276.69 — upside +12%
Today : $301.63 — upside +3%
🎯 on VEEV : no call matured yet · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Morgan Stanley ↗
Aug 27, 26
■ Equal-Weight neutral · not a buy · 🎯$275
Price at call : $282.13 — gap to target -3%
Today : $301.63 — gap to target -9%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Truist Securities ↗
Aug 27, 26
▲ Buy · 🎯$305
Price at call : $282.13 — upside +8%
Today : $301.63 — upside +1%
🎯 on VEEV : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Evercore ISI Group ↗
Aug 27, 26
■ In-Line neutral · not a buy · 🎯$250
Price at call : $282.13 — gap to target -11%
Today : $301.63 — gap to target -17%
🎯 on VEEV : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Buy · 🎯$310
Price at call : $282.13 — upside +10%
Today : $301.63 — upside +3%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
Piper Sandler ↗
Aug 27, 26
▲ Overweight · 🎯$320
Price at call : $282.13 — upside +13%
Today : $301.63 — upside +6%
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Aug 27, 27
matures : Aug 27, 27
▲ Buy · 🎯$270
Price at call : $248.46 — upside +9%
Today : $301.63 — upside -10%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Aug 24, 27
matures : Aug 24, 27
Guggenheim ↗
Aug 20, 26
▲ Buy · 🎯$276
Price at call : $250.53 — upside +10%
Today : $301.63 — upside -8%
🎯 on VEEV : no call matured yet · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Aug 20, 27
matures : Aug 20, 27
▲ Overweight · 🎯$275
Price at call : $242.75 — upside +13%
Today : $301.63 — upside -9%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 18, 27
matures : Aug 18, 27
Oppenheimer ↗
Aug 17, 26
▲ Outperform · 🎯$300
Price at call : $242.75 — upside +24%
Today : $301.63 — upside -1%
🎯 on VEEV : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
▲ Buy · 🎯$275
Price at call : $238.34 — upside +15%
Today : $301.63 — upside -9%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Aug 17, 27
matures : Aug 17, 27
Guggenheim ↗
Jul 23, 26
▲ Buy · 🎯$232
Price at call : $179.58 — upside +29%
Today : $301.63 — upside -23%
🎯 on VEEV : no call matured yet · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
■ Neutral neutral · not a buy · 🎯$190
Price at call : $172.61 — gap to target +10%
Today : $301.63 — gap to target -37%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Outperform · 🎯$270
Price at call : $172.61 — upside +56%
Today : $301.63 — upside -10%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Goldman Sachs ↗
Jun 4, 26
▼ Sell · 🎯$165
Price at call : $172.61 — upside -4%
Today : $301.63 — upside -45%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Oppenheimer ↗
Jun 4, 26
▲ Outperform · 🎯$225
Price at call : $172.61 — upside +30%
Today : $301.63 — upside -25%
🎯 on VEEV : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Canaccord Genuity ↗
Jun 4, 26
■ Hold neutral · not a buy · 🎯$220
Price at call : $172.61 — gap to target +27%
Today : $301.63 — gap to target -27%
🎯 on VEEV : no call matured yet · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$230
Price at call : $172.61 — upside +33%
Today : $301.63 — upside -24%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Evercore ISI Group ↗
Jun 4, 26
■ In-Line neutral · not a buy · 🎯$185
Price at call : $172.61 — gap to target +7%
Today : $301.63 — gap to target -39%
🎯 on VEEV : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
■ Neutral neutral · not a buy · 🎯$190
Price at call : $172.61 — gap to target +10%
Today : $301.63 — gap to target -37%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
RBC Capital ↗
Jun 4, 26
▲ Outperform · 🎯$275
Price at call : $172.61 — upside +59%
Today : $301.63 — upside -9%
🎯 on VEEV : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
BMO Capital ↗
Jun 4, 26
■ Market Perform neutral · not a buy · 🎯$175
Price at call : $178.6 — gap to target -2%
Today : $301.63 — gap to target -42%
🎯 on VEEV : no call matured yet · 📊 on Health : 60.4% · +8.8% (240 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Wells Fargo ↗
Jun 4, 26
▲ Overweight · 🎯$320
Price at call : $178.6 — upside +79%
Today : $301.63 — upside +6%
🎯 on VEEV : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Overweight · 🎯$235
Price at call : $178.6 — upside +32%
Today : $301.63 — upside -22%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Outperform · 🎯$260
Price at call : $178.6 — upside +46%
Today : $301.63 — upside -14%
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$340
Price at call : $178.6 — upside +90%
Today : $301.63 — upside +13%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$270
Price at call : $178.6 — upside +51%
Today : $301.63 — upside -10%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Piper Sandler ↗
Jun 4, 26
▲ Overweight · 🎯$235
Price at call : $178.6 — upside +32%
Today : $301.63 — upside -22%
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Oppenheimer ↗
May 18, 26
▲ Outperform · 🎯$225
Price at call : $163.85 — upside +37%
Today : $301.63 — upside -25%
🎯 on VEEV : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
■ Neutral neutral · not a buy · 🎯$176
Price at call : $158.45 — gap to target +11%
Today : $301.63 — gap to target -42%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
▲ Buy · 🎯$291
Price at call : $189.69 — upside +53%
Today : $301.63 — upside -4%
🎯 on VEEV : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Mar 9, 27
matures : Mar 9, 27
Canaccord Genuity ↗
Mar 5, 26
■ Hold neutral · not a buy · 🎯$235
Price at call : $195.49 — gap to target +20%
Today : $301.63 — gap to target -22%
🎯 on VEEV : no call matured yet · 📊 on Health : 52.6% · +5.0% (154 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
▲ Buy · 🎯$300
Price at call : $195.49 — upside +53%
Today : $301.63 — upside -1%
🎯 on VEEV : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
Wells Fargo ↗
Mar 5, 26
▲ Overweight · 🎯$317
Price at call : $195.49 — upside +62%
Today : $301.63 — upside +5%
🎯 on VEEV : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
▲ Buy · 🎯$245
Price at call : $195.49 — upside +25%
Today : $301.63 — upside -19%
🎯 on VEEV : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
Truist Securities ↗
Mar 5, 26
▲ Buy · 🎯$262
Price at call : $195.49 — upside +34%
Today : $301.63 — upside -13%
🎯 on VEEV : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
RBC Capital ↗
Mar 5, 26
▲ Outperform · 🎯$275
Price at call : $195.49 — upside +41%
Today : $301.63 — upside -9%
🎯 on VEEV : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
■ Neutral neutral · not a buy · 🎯$220
Price at call : $195.49 — gap to target +13%
Today : $301.63 — gap to target -27%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
Evercore ISI Group ↗
Mar 5, 26
■ In-Line neutral · not a buy · 🎯$240
Price at call : $195.49 — gap to target +23%
Today : $301.63 — gap to target -20%
🎯 on VEEV : no call matured yet · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
Morgan Stanley ↗
Mar 5, 26
■ Equal-Weight neutral · not a buy · 🎯$215
Price at call : $196.06 — gap to target +10%
Today : $301.63 — gap to target -29%
🎯 on VEEV : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
▲ Buy · 🎯$270
Price at call : $196.06 — upside +38%
Today : $301.63 — upside -10%
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
in progress (365j)
matures : Mar 5, 27
matures : Mar 5, 27
▲ Buy · 🎯$355
Price at call : $272.33 — upside +30%
Today : $301.63 — upside +18%
Expected +30% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+1.6%
stock +2% · XLV +25%
matured Aug 28, 26
Piper Sandler ↗
Aug 28, 25
▲ Overweight · 🎯$355
Price at call : $272.33 — upside +30%
Today : $301.63 — upside +18%
Expected +30% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+1.6%
stock +2% · XLV +25%
matured Aug 28, 26
Piper Sandler ↗
May 29, 25
▲ Overweight · 🎯$325
Price at call : $279.7 — upside +16%
Today : $301.63 — upside +8%
Expected +16% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-32.6%
stock -33% · XLV +11%
matured May 29, 26
▲ Buy · 🎯$300
Price at call : $279.04 — upside +8%
Today : $301.63 — upside -1%
Expected +8% · Actual -38% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-37.5%
stock -38% · XLV +13%
matured May 29, 26
Piper Sandler ↗
Apr 23, 25
▲ Overweight · 🎯$255
Price at call : $227.71 — upside +12%
Today : $301.63 — upside -15%
Expected +12% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-29.2%
stock -29% · XLV +5%
matured Apr 23, 26
▲ Outperform · 🎯$285
Price at call : $236.14 — upside +21%
Today : $301.63 — upside -6%
Expected +21% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-17.2%
stock -17% · XLV +2%
matured Mar 6, 26
▲ Buy · 🎯$270
Price at call : $236.14 — upside +14%
Today : $301.63 — upside -10%
Expected +14% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-17.2%
stock -17% · XLV +2%
matured Mar 6, 26
▲ Buy · 🎯$270
Price at call : $216.59 — upside +25%
Today : $301.63 — upside -10%
Expected +25% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-0.1%
stock -0% · XLV +11%
matured Jan 17, 26
▲ Outperform · 🎯$283
Price at call : $250.45 — upside +13%
Today : $301.63 — upside -6%
Expected +13% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-4.5%
stock -5% · XLV +5%
matured Dec 6, 25
▲ Buy · 🎯$270
Price at call : $250.45 — upside +8%
Today : $301.63 — upside -10%
Expected +8% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-4.5%
stock -5% · XLV +5%
matured Dec 6, 25
Piper Sandler ↗
Dec 6, 24
▲ Overweight · 🎯$290
Price at call : $250.45 — upside +16%
Today : $301.63 — upside -4%
Expected +16% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-4.5%
stock -5% · XLV +5%
matured Dec 6, 25
▲ Buy · 🎯$260
Price at call : $235 — upside +11%
Today : $301.63 — upside -14%
Expected +11% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+25.9%
stock +26% · XLV -2%
matured Nov 8, 25
Piper Sandler ↗
Nov 8, 24
▲ Overweight · 🎯$280
Price at call : $235 — upside +19%
Today : $301.63 — upside -7%
Expected +19% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+25.9%
stock +26% · XLV -2%
matured Nov 8, 25
▲ Outperform · 🎯$245
Price at call : $212.13 — upside +15%
Today : $301.63 — upside -19%
Expected +15% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+37.4%
stock +37% · XLV -2%
matured Oct 28, 25
▲ Outperform · 🎯$251
Price at call : $217.02 — upside +16%
Today : $301.63 — upside -17%
Expected +16% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+24.0%
stock +24% · XLV -12%
matured Aug 29, 25
▲ Buy · 🎯$260
Price at call : $217.02 — upside +20%
Today : $301.63 — upside -14%
Expected +20% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+24.0%
stock +24% · XLV -12%
matured Aug 29, 25
Piper Sandler ↗
Aug 29, 24
▲ Overweight · 🎯$230
Price at call : $217.02 — upside +6%
Today : $301.63 — upside -24%
Expected +6% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+24.0%
stock +24% · XLV -12%
matured Aug 29, 25
▲ Buy · 🎯$260
Price at call : $187.16 — upside +39%
Today : $301.63 — upside -14%
Expected +39% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+50.9%
stock +51% · XLV -10%
matured Jul 15, 25
Piper Sandler ↗
Jul 12, 24
▲ Overweight · 🎯$225
Price at call : $187.92 — upside +20%
Today : $301.63 — upside -25%
Expected +20% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+50.2%
stock +50% · XLV -9%
matured Jul 12, 25
▲ Outperform · 🎯$245
Price at call : $174.25 — upside +41%
Today : $301.63 — upside -19%
Expected +41% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+59.9%
stock +60% · XLV -8%
matured May 31, 25
▲ Buy · 🎯$260
Price at call : $174.25 — upside +49%
Today : $301.63 — upside -14%
Expected +49% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+59.9%
stock +60% · XLV -8%
matured May 31, 25
Piper Sandler ↗
May 31, 24
▲ Overweight · 🎯$235
Price at call : $174.25 — upside +35%
Today : $301.63 — upside -22%
Expected +35% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+59.9%
stock +60% · XLV -8%
matured May 31, 25
▲ Outperform · 🎯$255
Price at call : $200.5 — upside +27%
Today : $301.63 — upside -15%
Expected +27% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+39.2%
stock +39% · XLV -7%
matured May 29, 25
▲ Buy · 🎯$260
Price at call : $216.41 — upside +20%
Today : $301.63 — upside -14%
Expected +20% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+4.7%
stock +5% · XLV +0%
matured Apr 2, 25
▲ Outperform · 🎯$251
Price at call : $226 — upside +11%
Today : $301.63 — upside -17%
Expected +11% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-3.1%
stock -3% · XLV +2%
matured Mar 1, 25
▲ Buy · 🎯$260
Price at call : $222.01 — upside +17%
Today : $301.63 — upside -14%
Expected +17% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
-1.4%
stock -1% · XLV +2%
matured Mar 1, 25
Piper Sandler ↗
Mar 1, 24
▲ Overweight · 🎯$245
Price at call : $222.01 — upside +10%
Today : $301.63 — upside -19%
Expected +10% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-1.4%
stock -1% · XLV +2%
matured Mar 1, 25
Piper Sandler ↗
Jan 2, 24
▲ Overweight · 🎯$220
Price at call : $185.19 — upside +19%
Today : $301.63 — upside -27%
Expected +19% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+13.7%
stock +14% · XLV -1%
matured Jan 1, 25
▲ Buy · 🎯$220
Price at call : $172.95 — upside +27%
Today : $301.63 — upside -27%
Expected +27% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 58% (12 calls matureds) · 📊 on Health : 48.8% · +2.3% (160 calls)
+44.8%
stock +45% · XLV +9%
matured Dec 6, 24
Piper Sandler ↗
Dec 7, 23
▲ Overweight · 🎯$200
Price at call : $172.95 — upside +16%
Today : $301.63 — upside -34%
Expected +16% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+44.8%
stock +45% · XLV +9%
matured Dec 6, 24
Piper Sandler ↗
Nov 10, 23
▲ Overweight · 🎯$200
Price at call : $165.08 — upside +21%
Today : $301.63 — upside -34%
Expected +21% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on VEEV : 67% (12 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
+43.5%
stock +43% · XLV +18%
matured Nov 9, 24
▲ Outperform · 🎯$242
Price at call : $209.01 — upside +16%
Today : $301.63 — upside -20%
Expected +16% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+3.8%
stock +4% · XLV +19%
matured Sep 13, 24
▲ Outperform · 🎯$242
Price at call : $216.57 — upside +12%
Today : $301.63 — upside -20%
Expected +12% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-0.4%
stock -0% · XLV +17%
matured Aug 30, 24
▲ Outperform · 🎯$235
Price at call : $196.44 — upside +20%
Today : $301.63 — upside -22%
Expected +20% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-7.5%
stock -8% · XLV +10%
matured Jun 29, 24
▲ Outperform · 🎯$235
Price at call : $198.3 — upside +19%
Today : $301.63 — upside -22%
Expected +19% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on VEEV : 50% (12 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-12.1%
stock -12% · XLV +12%
matured May 31, 24
Frequently asked questions
Should I buy Veeva Systems stock?
This isn't buy advice. For Veeva Systems, the analyst consensus is "Buy", with an average price target of $295 (-2% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Veeva Systems). We show the numbers — you decide.
Is it too late to buy Veeva Systems? How high can it go?
The most bullish analyst target on Veeva Systems is $340 (+13% above today's price); the average is $295. That's the upside they see. Check how reliable those analysts have actually been on Veeva Systems on our site before trusting it.
Is Veeva Systems still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 29 analysts have a real record on Veeva Systems, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Veeva Systems? The case for and against
The arguments for and against, one by one, from the numbers: why invest in VEEV (and why hesitate).
What has Veeva Systems's past performance been?
Historical returns and a "how much if I had invested" calculator: VEEV performance & returns.
What is the best month to buy VEEV?
The 12 months ranked by the stock's past returns: best & worst month to buy VEEV.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
BSX 
LLY